A
38.02
-0.78 (-2.02%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bearish |
| Biotechnology (Global) | Mixed | Bearish | |
| Stock | Apellis Pharmaceuticals, Inc. | Bullish | Bullish |
Stockmoo Score
2.6
|
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Growth |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 96.00 (Baird, 152.53%) | Buy |
| Median | 81.50 (114.39%) | |
| Low | 41.00 (Wedbush, 7.85%) | Hold |
| Average | 74.88 (96.98%) | |
| Total | 7 Buy, 1 Hold | |
| Avg. Price @ Call | 37.35 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| JP Morgan | 13 Sep 2024 | 57.00 (49.94%) | Buy | 37.62 |
| 13 Aug 2024 | 64.00 (68.35%) | Buy | 35.72 | |
| Baird | 09 Aug 2024 | 96.00 (152.53%) | Buy | 37.01 |
| 26 Jul 2024 | 86.00 (126.23%) | Buy | 39.75 | |
| Goldman Sachs | 09 Aug 2024 | 74.00 (94.66%) | Buy | 37.01 |
| 02 Aug 2024 | 66.00 (73.62%) | Buy | 36.56 | |
| Needham | 09 Aug 2024 | 85.00 (123.60%) | Buy | 37.01 |
| 02 Aug 2024 | 85.00 (123.60%) | Buy | 36.56 | |
| UBS | 09 Aug 2024 | 83.00 (118.33%) | Buy | 37.01 |
| Wedbush | 09 Aug 2024 | 41.00 (7.85%) | Hold | 37.01 |
| HC Wainwright & Co. | 02 Aug 2024 | 83.00 (118.33%) | Buy | 36.56 |
| Jefferies | 31 Jul 2024 | 80.00 (110.44%) | Buy | 39.60 |
| Show more | ||||
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| CHOPAS JAMES GEORGE | - | 38.80 | -550 | -21,340 |
| Aggregate Net Quantity | -550 | |||
| Aggregate Net Value ($) | -21,340 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 38.80 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| CHOPAS JAMES GEORGE | Officer | 03 Sep 2024 | Sell (-) | 550 | 38.80 | 21,340 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |